 |
Doug Macron is the editor of GenomeWeb's Gene Silencing News. He covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies. E-mail Doug Macron or follow his GenomeWeb Twitter account at @Genesilencing. |
USPTO Gives OK to Santaris Request for Re-Exam of Regulus miR-122 Patent
January 10, 2013
USPTO Gives OK to Santaris Request for Re-Exam of Regulus miR-122 Patent
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- IP Update: Recent Patents, Patent Applications Awarded to Santaris, Nitto Denko, BASF, and More
May 16, 2013 / Gene Silencing News - IP Update: Recent Patents, Patent Applications Awarded to Max Planck, UMass, Santaris, and More
December 13, 2012 / Gene Silencing News - IP Update: Recent Patents, Patent Applications Awarded to Opko, Alnylam, Santaris, and More
October 18, 2012 / Gene Silencing News - IP Update: Recent Patents, Patent Applications Awarded to Merck, Alnylam, Regulus, and More
June 28, 2012 / Gene Silencing News - IP Update: Recent Patents, Patent Applications Awarded to Alnylam, Santaris, Medtronic, and More
April 26, 2012 / Gene Silencing News